These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36934022)

  • 21. [Clinical Features of Myasthenia Gravis as an Immune-related Adverse Event].
    Suzuki S
    Brain Nerve; 2024 Jan; 76(1):27-32. PubMed ID: 38191136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS and PNS manifestation in immune checkpoint inhibitors: A systematic review.
    Khan E; Shrestha AK; Elkhooly M; Wilson H; Ebbert M; Srivastava S; Wen S; Rollins S; Sriwastava S
    J Neurol Sci; 2022 Jan; 432():120089. PubMed ID: 34942546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Checkpoint Inhibition-Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade.
    Nelke C; Pawlitzki M; Kerkhoff R; Schroeter CB; Aktas O; Neuen-Jacob E; Polzin A; Meuth SG; Ruck T
    Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):. PubMed ID: 37884388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.
    Deharo F; Carvelli J; Cautela J; Garcia M; Sarles C; Maues de Paula A; Bourenne J; Gainnier M; Bichon A
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.
    Marini A; Bernardini A; Gigli GL; Valente M; Muñiz-Castrillo S; Honnorat J; Vogrig A
    Neurology; 2021 Apr; 96(16):754-766. PubMed ID: 33653902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study.
    Fonseca E; Cabrera-Maqueda JM; Ruiz-García R; Naranjo L; Diaz-Pedroche C; Velasco R; Macias-Gómez A; Milisenda JC; Muñoz-Farjas E; Pascual-Goñi E; Gállego Perez-Larraya J; Saiz A; Dalmau J; Blanco Y; Graus F; Martinez-Hernandez E;
    Lancet Neurol; 2023 Dec; 22(12):1150-1159. PubMed ID: 37977714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe neurologic complications of immune checkpoint inhibitors: a single-center review.
    Mancone S; Lycan T; Ahmed T; Topaloglu U; Dothard A; Petty WJ; Strowd RE
    J Neurol; 2018 Jul; 265(7):1636-1642. PubMed ID: 29761297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Checkpoint Inhibitor-induced Myositis.
    Jayan A; Mammen AL; Suarez-Almazor ME
    Rheum Dis Clin North Am; 2024 May; 50(2):281-290. PubMed ID: 38670726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.
    Pathak R; Katel A; Massarelli E; Villaflor VM; Sun V; Salgia R
    Oncologist; 2021 Dec; 26(12):1052-1061. PubMed ID: 34378270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update.
    Dang QM; Watanabe R; Shiomi M; Fukumoto K; Nobashi TW; Okano T; Yamada S; Hashimoto M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors.
    Jordan B; Benesova K; Hassel JC; Wick W; Jordan K
    ESMO Open; 2021 Dec; 6(6):100317. PubMed ID: 34839103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders.
    Aoun R; Gratch D; Kaminetzky D; Kister I
    Curr Neurol Neurosci Rep; 2023 Nov; 23(11):735-750. PubMed ID: 37870664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody.
    Ono R; Iwai Y; Yamazaki T; Takahashi H; Hori Y; Fukushima K; Saotome T
    Intern Med; 2022 Oct; 61(19):2973-2979. PubMed ID: 35314545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatment.
    Psimaras D; Velasco R; Birzu C; Tamburin S; Lustberg M; Bruna J; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S74-S85. PubMed ID: 31393660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies in Patients With Immune-Related Adverse Events From Checkpoint Inhibitors: A Systematic Literature Review.
    Ghosh N; Chan KK; Jivanelli B; Bass AR
    J Clin Rheumatol; 2022 Mar; 28(2):e498-e505. PubMed ID: 34371516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors.
    Dinoto A; Trentinaglia M; Carta S; Mantovani E; Ferrari S; Tamburin S; Tinazzi M; Mariotto S
    Mov Disord Clin Pract; 2024 May; 11(5):543-549. PubMed ID: 38400610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system adverse events of immune checkpoint inhibitors.
    Farina A; Villagrán-García M; Vogrig A; Joubert B
    Curr Opin Neurol; 2024 Jun; 37(3):345-352. PubMed ID: 38483130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy.
    Saygin D; Ghosh N; Reid P
    J Clin Rheumatol; 2022 Oct; 28(7):367-373. PubMed ID: 35696731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances on immune-related adverse events associated with immune checkpoint inhibitors.
    Fan Y; Geng Y; Shen L; Zhang Z
    Front Med; 2021 Feb; 15(1):33-42. PubMed ID: 32779094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune checkpoint inhibitor-associated myasthenia gravis, myositis, and myocarditis overlap syndrome.
    Lipe DN; Galvis-Carvajal E; Rajha E; Wechsler AH; Gaeta S
    Am J Emerg Med; 2021 Aug; 46():51-55. PubMed ID: 33721590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.